- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] Uncontrolled in Russian Federation
Total 334 results
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Besins HealthcareCompletedHypogonadism | T2DM (Type 2 Diabetes Mellitus)Russian Federation
-
SanofiCompleted
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)Russian Federation
-
Materia Medica HoldingCompletedType II Diabetes MellitusRussian Federation
-
Research Clinical Centre of the Russian Railways...UnknownDiabetes Mellitus | Hypoglycemic EpisodesRussian Federation
-
AstraZenecaCompletedType 2 DiabetesRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Russian Federation
-
Endocrinology Research Centre, MoscowCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Russian Federation
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedType 2 DiabetesRussian Federation
-
Tomsk National Research Medical Center of the Russian...CompletedHypertension | Type 2 Diabetes MellitusRussian Federation
-
Becton, Dickinson and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | LipohypertrophyRussian Federation
-
Federal State Budgetary Institution, V. A. Almazov...Tameside Hospital NHS Foundation TrustCompletedDiabetic Neuropathies | Vitamin D Deficiency | Diabetes Type 2Russian Federation
-
GeropharmCompletedClamp StudyRussian Federation
-
Institute for Atherosclerosis Research, RussiaCompletedDiabetes Mellitus, Type 2 | Diabetes ComplicationsRussian Federation
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusRussian Federation, Poland
-
Astellas Pharma IncCompletedDiabetes Mellitus Type 2Russian Federation
-
AstraZenecaBiocardCompletedDiabetes Mellitus, Type 2Russian Federation
-
Astana Medical UniversityUnknownType 2 DiabetesKazakhstan, Russian Federation
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusRussian Federation
-
SanofiCompletedType 2 Diabetes MellitusLebanon, Russian Federation, Ukraine
-
Irina ErmolaevaRecruitingChronic Kidney Diseases | Atrial Fibrillation | T2DM (Type 2 Diabetes Mellitus)Russian Federation
-
Federal State Budgetary Institution, V. A. Almazov...UnknownDiabetes Mellitus, Type 2Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRussian Federation, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Russian Federation
-
SanofiCompleted
-
Mannkind CorporationCompletedDiabetes Type 2Russian Federation
-
Materia Medica HoldingCompletedType I Diabetes MellitusRussian Federation
-
National Medical Research Center for Cardiology...Ministry of Health of the Russian FederationCompletedDiabetes Mellitus, Type 2 | Heart Failure, DiastolicRussian Federation
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Brazil, Poland, Romania, Russian Federation, Ukraine
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Atlas BiomedCompletedStudy of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes MellitusDiabetes Mellitus, Type 2 | Genetic Predisposition | MetagenomeRussian Federation
-
GeropharmUnknownEfficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus PatientsDiabetes Mellitus, Type 2 | Diabetes MellitusRussian Federation
-
Akros Pharma Inc.CompletedType II Diabetes MellitusUnited States, Russian Federation, Czech Republic, Hungary, Netherlands
-
Abbott NutritionCompletedDiabetes Mellitus, Type 2Russian Federation
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, Romania, United States, India, Puerto Rico
-
GeropharmCompletedDiabetes Mellitus, Type 2Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
SanofiCompletedType 2 Diabetes MellitusChina, India, Korea, Republic of, Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRussian Federation
-
Charite University, Berlin, GermanyUniversity of Hull; IRCCS San Raffaele; Hannover Medical School; Russian Cardiology... and other collaboratorsCompletedHeart Failure | Type 2 Diabetes MellitusGermany, Slovenia, United Kingdom, Italy, Poland, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Spain, China, India, Russian Federation, Turkey, Germany, Japan, United Kingdom, France, United States
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines